Form 8-K Lucid Diagnostics Inc. For: Nov 13

Go back to Form 8-K Lucid Diagnostics Inc. For: Nov 13

Lucid Diagnostics Inc (LUCD) PT Lowered to $3.80 at Cantor Fitzgerald

November 14, 2023 2:31 PM EST

Cantor Fitzgerald analyst Ross Osborn lowered the price target on Lucid Diagnostics Inc (NASDAQ: LUCD) to $3.80 (from $4.00) while maintaining a Overweight rating.

The analyst comments "

Investment Summary. We reiterate our Overweight rating while we moderate our 12-month price target to $3.80 from $4.00 on Lucid... More